Dr. Herrod is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
286 S Lenzner Ave
Sierra Vista, AZ 85635Phone+1 520-452-0388Fax+1 520-452-0379- Is this information wrong?
Education & Training
LDS HospitalResidency, Internal Medicine, 1984 - 1986
Loma Linda University Health Education ConsortiumInternship, Internal Medicine, 1983 - 1984
University of Utah School of MedicineClass of 1983
Certifications & Licensure
AZ State Medical License 1995 - 2026
UT State Medical License 1984 - 2002
Clinical Trials
- Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics Start of enrollment: 2011 Mar 01
Publications & Presentations
PubMed
- 19 citationsValomaciclovir versus valacyclovir for the treatment of acute herpes zoster in immunocompetent adults: a randomized, double-blind, active-controlled trial.Stephen K. Tyring, Stephanie Plunkett, Anita R. Scribner, Robert E. Broker, John N. Herrod, Lane T. Handke, John M. Wise, Paul A. Martin> ;Journal of Medical Virology. 2012 Aug 1
- 4 citationsComparative efficacy and safety of cefprozil and cefaclor in the treatment of acute uncomplicated urinary tract infections.John C. Christenson, W. Manford Gooch, John N. Herrod, Elise Swenson> ;The Journal of Antimicrobial Chemotherapy. 1991 Oct 1
- Comparative efficacy and safety of cefprozil (BMY-28100) and cefaclor in the treatment of acute group A beta-hemolytic streptococcal pharyngitis.Christenson, J. C., Swenson, E., Gooch, W. M., Herrod, J. N.> ;Antimicrob Agents Chemother. 1991 Jun
Hospital Affiliations
TMC HealthCareTucson, Arizona
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
